100 related articles for article (PubMed ID: 10077433)
1. In vitro and in vivo vasodilatory activity of barnidipine and its enantiomers.
Inagaki O; Asano M; Takenaka T
Biol Pharm Bull; 1999 Feb; 22(2):151-6. PubMed ID: 10077433
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist.
van Zwieten PA
Blood Press Suppl; 1998; 1():5-8. PubMed ID: 9660520
[TBL] [Abstract][Full Text] [Related]
3. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Tamazawa K; Arima H; Kojima T; Isomura Y; Okada M; Fujita S; Furuya T; Takenaka T; Inagaki O; Terai M
J Med Chem; 1986 Dec; 29(12):2504-11. PubMed ID: 3023614
[TBL] [Abstract][Full Text] [Related]
4. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride.
Nakayama K; Kashiwabara T; Yamada S; Tanaka Y
Arzneimittelforschung; 1989 Jan; 39(1):50-5. PubMed ID: 2470382
[TBL] [Abstract][Full Text] [Related]
5. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
[TBL] [Abstract][Full Text] [Related]
6. Barnidipine, a long-acting slow onset calcium antagonist.
Korstanje C
Int J Clin Pract Suppl; 2000 Nov; (114):2-5. PubMed ID: 11221290
[TBL] [Abstract][Full Text] [Related]
7. Effect of barnidipine on blood flow to major organs and renal function in anaesthetized dogs and spontaneously hypertensive rats.
Saitoh M; Kasai C; Ishikawa J; Masaki K; Asano M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S339-40. PubMed ID: 9072419
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
9. Differential time course of the vasodilator action of various calcium antagonists.
van der Lee R; Kam KL; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1998; 12(6):607-12. PubMed ID: 9818292
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent effects of barnidipine in rat vascular smooth muscle.
Wegener JW; Korstanje C; Nawrath H
J Cardiovasc Pharmacol; 2003 Aug; 42(2):218-23. PubMed ID: 12883325
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
12. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
13. Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats.
Janssen BJ; Kam KL; Smits JF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):414-21. PubMed ID: 11692224
[TBL] [Abstract][Full Text] [Related]
14. CD-832, a new dihydropyridine derivative with both nitrate-like and Ca2+ channel antagonist vasodilator activities.
Miyata N; Yamaura H; Tanaka M; Takahashi K; Tsuchida K; Otomo S
Eur J Pharmacol; 1993 Nov; 249(2):141-9. PubMed ID: 8287896
[TBL] [Abstract][Full Text] [Related]
15. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
16. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
[TBL] [Abstract][Full Text] [Related]
17. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
Teramura T; Watanabe T; Higuchi S; Hashimoto K
Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110.
Hof RP; Hof A; Ruegg UT; Cook NS; Vogel A
J Cardiovasc Pharmacol; 1986; 8(2):221-6. PubMed ID: 2422457
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective syntheses and calcium channel modulating effects of (+)- and (-)-3-isopropyl 5-(4-methylphenethyll) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinedicarboxylates.
Iqbal N; Vo D; McEwen CA; Wolowyk MW; Knaus EE
Chirality; 1994; 6(7):515-20. PubMed ID: 7986665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
